Orakl Oncology

Orakl Oncology builds a drug-testing platform that models how cancer patients respond to therapies, using patient-derived biology to create virtual representations of tumors. Pharmaceutical teams use the platform to predict treatment response and de-risk oncology development programs before human trials.

  • Series A
  • Biotechnology
  • Clinical Trials
  • Healthtech
  • Pharmaceuticals
  • Healthcare & Life Sciences

1

Round

1

Industry

5

Tags

Nov 12, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Nov 12, 2026

    $34M

    Series A

    Led by Norrsken VC

    • InfraVia
    • Bpifrance
    • Speedinvest
    • Verve Ventures
    • Serena (lead, via InnovAllianz III)
    • Plug and Play Tech Center
    • Norrsken VC
    • Singular
    • HCVC
    • Teampact Ventures

    Orakl Oncology Raises $34M Series A Led by Norrsken VC

    Orakl Oncology Closes $34M Series A Orakl Oncology, a developer of a drug testing platform for oncology, has raised $34 million in Series A funding. The round…

    Read article

Pricing

Research Orakl Oncology — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if Orakl Oncology is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational